We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Regulatory watch: Where do new medicines originate from in the EU?
- Authors
Lincker, Helene; Ziogas, Constantinos; Carr, Melanie; Porta, Nuria; Eichler, Hans-Georg
- Abstract
The article reports on the research on the geographical inception of organizations involved in the development of new drugs in the European Union (EU). It mentions a list of medicines with a new active substance (NAS) acknowledged by the Committee for Medicinal Products for Human Use (CHMP) and compiled at the European Medicines Agency (EMA). An overview of analysis on product transfers in various categories of originators and marketing authorization holders is also presented.
- Subjects
EUROPEAN Union countries; DRUG development; EUROPEAN Union; EUROPEAN Medicines Agency; MARKS of origin; COUNTRY of origin (Commerce)
- Publication
Nature Reviews Drug Discovery, 2014, Vol 13, Issue 2, p92
- ISSN
1474-1776
- Publication type
Article
- DOI
10.1038/nrd4232